26.11.2012 Views

Peptide-Based Drug Design

Peptide-Based Drug Design

Peptide-Based Drug Design

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Lipopeptides 255<br />

Representative results of HPLC chromatograms and mass spectra that we have<br />

obtained are shown in Fig. 1. Also shown are schematic representations of the<br />

peptide and lipopeptide structures.<br />

3.4. Evaluation of Vaccine Efficacy<br />

There are many techniques that can be employed to assess the immunogenicity<br />

of a vaccine candidate, and laboratories interested in pursuing this<br />

objective should also explore other assays suited to their purposes. In this<br />

model, vaccine immunogenicity is measured by determining levels of anti-<br />

LHRH antibodies induced in mice immunized with lipopeptide or a nonlipidated<br />

peptide control. It is important to correlate vaccine immunogenicity with<br />

biological function, and we measure the reproductively capability of vaccinated<br />

female mice as an indication of vaccine efficacy. Techniques that determine<br />

testosterone and oestrogen levels are also useful.<br />

3.4.1. Immunization of Mice<br />

1. Dissolve peptide and lipopeptide vaccines in saline to a concentration of 200<br />

nmol/mL. If necessary, encourage dissolution by warming in a water bath and/or<br />

by sonication. Do not mix by pipet if the inoculant is not soluble; this can result in<br />

insoluble peptide or lipopeptide being trapped in the pipet tip.<br />

2. Immunise 6- to 8-week-old female BALB/c or C57BL6 mice either intranasally<br />

or subcutaneously in the base of the tail with 20 nmol (100 �L) of lipopeptide or<br />

nonlipidated peptide in saline per dose.<br />

3. Perform booster inoculations using the same amount of peptide and lipopeptide 4<br />

wk later (see Note 5).<br />

4. Obtain blood 2 wk following the second dose of vaccine (see Note 6).<br />

5. Prepare sera by leaving blood overnight at 4 ◦ C to coagulate.<br />

6. Centrifuge tubes containing coagulated blood to separate sera.<br />

7. Collect sera and store at −20 ◦ C or use immediately.<br />

3.4.2. Enzyme-Linked Immunosorbent Assay (ELISA)<br />

The working principle of the ELISA described here involves the use of<br />

LHRH peptide-coated wells to capture any anti-LHRH antibodies present in<br />

the sera of vaccinated mice. Captured antibodies are detected through the use<br />

of a horseradish peroxidase-conjugated antibody that is specific for mouse<br />

immunoglobulins and a substrate is then added to induce a color change. In<br />

this case, the substrate utilized is 2,2´-azino-bis 3-ethylbenzthiazoline-sulfonic<br />

acid (ABTS; Sigma-Aldrich, USA), which is converted to a green soluble end<br />

product by horseradish peroxidase (see Note 7). The level of substrate-induced

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!